04:25:14 EDT Fri 10 Jul 2026
Enter Symbol
or Name
USA
CA



Apotex Health Corp
Symbol APTX
Shares Issued 228,499,020
Close 2026-07-09 C$ 37.69
Market Cap C$ 8,612,128,064
Recent Sedar+ Documents

Apotex Health to release Q1 2027 results on Aug. 12

2026-07-09 22:08 ET - News Release

An anonymous director reports

APOTEX TO ANNOUNCE FIRST QUARTER FISCAL 2027 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON AUGUST 12, 2026

Apotex Health Corp. will issue a news release with its first quarter fiscal 2027 financial results on Wednesday, Aug. 12, 2026, at approximately 6 a.m. ET. Apotex will host a conference call and live webcast to discuss the results at 8 a.m. ET.

A live webcast of the call will be available on the company's website. The call can also be accessed live by dialling 416-945-7677 locally or 1-888-699-1199 toll-free from North America.

Following the conclusion of the call, a replay of the webcast will be available on Apotex's website.

About Apotex Health Corp.

Apotex is a Canadian-based global health company. The company improves everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico and India, Apotex is the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.

© 2026 Canjex Publishing Ltd. All rights reserved.